Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR

Matthias Ritgen(Goethe University Frankfurt), Peter Dreger(Heidelberg University), Alexander Kröber(Leibniz University Hannover), Andreas Humpe(Munich University of Applied Sciences), Stephan Stilgenbauer(Universität Ulm), Nils von Neuhoff(Leibniz University Hannover), Richard F. Schlenk(German Cancer Research Center), Michael Kneba(Universitäts Hautklinik Kiel), Thorsten Raff(Goethe University Frankfurt), Monika Brüggemann(University Hospital Schleswig-Holstein), Hartmut Döhner(University Hospital Ulm), Norbert Schmitz(University Hospital Münster), Christiane Pott(University Hospital Schleswig-Holstein), Donald Bunjes(University Hospital Ulm)
Blood
June 18, 2004
10.1182/blood-2003-12-4321
Cited by 170

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
|Blood|2009|3.4k
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k